MET:NYE-MetLife Inc. (USD)

EQUITY | Insurance - Life | New York Stock Exchange

Last Closing

USD 73.13

Change

-0.18 (-0.25)%

Market Cap

USD 60.38B

Volume

2.33M

Analyst Target

USD 45.73
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

MetLife Inc is a provider of insurance, annuities & employee benefit programs in United States, Japan, Latin America, Asia, Europe & Middle East. It offers life insurance, annuities, property & casualty insurance, and other financial services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
AFL Aflac Incorporated

+0.09 (+0.08%)

USD 61.65B
MET-PA MetLife Inc Preferred Stock Se..

+0.17 (+0.69%)

USD 47.76B
PRU Prudential Financial Inc

+1.37 (+1.09%)

USD 44.68B
MET-PE MetLife Inc Preferred Stock Se..

+0.03 (+0.12%)

USD 44.02B
PUK Prudential Public Limited Comp..

-0.18 (-1.07%)

USD 23.52B
PRI Primerica Inc

+1.83 (+0.66%)

USD 9.37B
JXN Jackson Financial Inc

+0.80 (+0.78%)

USD 7.44B
FG F&G Annuities & Life Inc.

-0.15 (-0.36%)

USD 5.38B
ANG-PA American National Group Inc.

+0.11 (+0.44%)

N/A
MET-PF MetLife Inc Preferred Stock Se..

-0.02 (-0.09%)

N/A

ETFs Containing MET

FLI:CA CI U.S. & Canada Lifeco C.. 10.06 % 0.92 %

+0.06 (+0.03%)

CAD 0.09B
JEDG:LSE VanEck Space Innovators U.. 5.13 % 0.00 %

-0.08 (0.03%)

N/A
JEDI:LSE VanEck Space Innovators U.. 5.13 % 0.00 %

-0.10 (0.03%)

N/A
YODA:PA 4.92 % 0.00 %

N/A

N/A
YODA:XETRA 4.92 % 0.00 %

N/A

N/A
UFOP:LSE 4.86 % 0.00 %

N/A

N/A
YODA:LSE 4.86 % 0.00 %

N/A

N/A
PJFV PGIM ETF Trust - PGIM Jen.. 3.64 % 0.00 %

+0.14 (+0.03%)

N/A
TEQI T. Rowe Price Equity Inco.. 2.06 % 0.00 %

+0.01 (+0.03%)

USD 0.25B
AGED:SW iShares Ageing Population.. 0.58 % 0.00 %

N/A

N/A
VVLU:AU Vanguard Global Value Equ.. 0.36 % 0.00 %

-0.35 (0.03%)

USD 0.63B
EUSA iShares MSCI USA Equal We.. 0.20 % 0.15 %

-0.13 (0.03%)

USD 0.92B
FHF:CA 0.00 % 0.77 %

N/A

N/A
IAK iShares U.S. Insurance ET.. 0.00 % 0.43 %

+0.52 (+0.03%)

N/A
JPHF 0.00 % 0.79 %

N/A

N/A
PXLV Invesco S&P 500 Value wit.. 0.00 % 0.39 %

+0.17 (+0.03%)

N/A
IVFVC 0.00 % 0.00 %

N/A

N/A
JPLS 0.00 % 0.60 %

N/A

N/A
RWW 0.00 % 0.46 %

N/A

N/A
RWW 0.00 % 0.00 %

N/A

N/A
RWW 0.00 % 0.69 %

N/A

N/A
RWW 0.00 % 0.00 %

N/A

N/A
RWW 0.00 % 0.46 %

N/A

N/A
2B77:XETRA iShares Ageing Population.. 0.00 % 0.00 %

-0.04 (0.03%)

USD 0.50B
VLIQ:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.59% 68% D+ 74% C
Dividend Return 1.61% 72% C 63% D
Total Return 12.20% 70% C- 76% C+
Trailing 12 Months  
Capital Gain 41.45% 79% B- 87% B+
Dividend Return 4.07% 53% F 60% D-
Total Return 45.52% 80% B- 88% B+
Trailing 5 Years  
Capital Gain 54.51% 58% F 71% C-
Dividend Return 20.50% 82% B 73% C
Total Return 75.02% 54% F 75% C
Average Annual (5 Year Horizon)  
Capital Gain 13.01% 65% D 76% C+
Dividend Return 16.62% 70% C- 79% B-
Total Return 3.61% 47% F 68% D+
Risk Return Profile  
Volatility (Standard Deviation) 32.97% 25% F 33% F
Risk Adjusted Return 50.42% 55% F 73% C
Market Capitalization 60.38B 100% F 95% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Insurance - Life) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.80 21% 31%
Price/Book Ratio 1.69 20% 48%
Price / Cash Flow Ratio 3.69 59% 68%
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity 7.82% 30% 49%
Return on Invested Capital 2.31% 35% 32%
Return on Assets 0.37% 50% 25%
Debt to Equity Ratio 62.23% 26% 53%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector